Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Meclin (meclizine hydrochloride) to Draminn (dimenhydrinate) for control of acute vertigo of peripheral origin; study completed with non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dramin (dimenhydrinate)
  • Meclin (meclizine hydrochloride)

Snippet

Sponsor: Apsen Farmaceutica S.A. | Conditions: Vertigo, Peripheral | Phase 3 | Status: COMPLETED